Strategic Regulatory Planning Flashcards
7 cards from real RAC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Strategic Regulatory Planning flashcards as text
Which concept describes a regulatory strategy that sequences market entries to use data from one region to support applications in others?
Answer: Regulatory leveraging or data bridging strategy
Regulatory leveraging (data bridging) uses approved data packages from one region as foundational support for submissions in other jurisdictions, reducing redundant studies.
A strategic regulatory plan should include contingency scenarios primarily because:
Answer: Unexpected agency feedback, clinical failures, or policy changes can derail timelines without alternatives ready
Contingency planning prepares teams to respond quickly to regulatory setbacks, clinical surprises, or guideline changes without losing critical development time.
Under the EU regulatory framework, which procedure allows a centralized single application valid across all EU member states?
Answer: Centralized Procedure (CP) via EMA
The Centralized Procedure through EMA results in a single marketing authorization valid across all EU/EEA member states, making it strategically advantageous for broad EU access.
What is the strategic significance of the FDA's 505(b)(2) pathway compared to a full NDA?
Answer: It allows reliance on published literature or FDA's prior findings, reducing the data package needed
The 505(b)(2) pathway enables applicants to rely on existing FDA findings of safety and efficacy, significantly reducing development costs and timelines versus a full standalone NDA.
When planning a regulatory strategy for an orphan drug in the US, which benefit is most strategically valuable?
Answer: Seven years of market exclusivity post-approval
Orphan Drug Designation grants 7 years of US market exclusivity after approval, which is a major commercial and strategic incentive for developing treatments for rare diseases.
Which regulatory strategy element addresses how a company will respond if FDA issues a Complete Response Letter (CRL)?
Answer: Resubmission and response strategy in the contingency plan
A resubmission and response strategy within the contingency plan defines timelines, resources, and decision criteria for addressing a CRL to minimize approval delays.
In strategic regulatory planning, 'regulatory intelligence' refers to:
Answer: Systematic monitoring of agency guidance, decisions, and policy trends to inform strategy
Regulatory intelligence involves tracking agency guidance documents, precedent decisions, policy shifts, and advisory committee trends to proactively shape development strategy.